Like mitochondria, chloroplasts are thought to have evolved from an ancestral endosymbiotic photosynthetic bacterium (see Figure 12-7). However, the endosymbiotic event that gave rise to chloroplasts occurred more recently (1.2 billion–
In higher plants, chloroplast DNA molecules are 120–
561
Methods similar to those used for the transformation of yeast cells (see Chapter 6) have been developed for stably introducing foreign DNA into the chloroplasts of higher plants. The large number of chloroplast DNA molecules per cell permits the introduction of thousands of copies of an engineered gene into each cell, resulting in extraordinarily high levels of foreign protein production, comparable with that achieved with engineered bacteria. Chloroplast transformation has led to the engineering of plants that are resistant to bacterial and fungal infections, drought, and herbicides as well as to plants that can be used to make human pharmaceutical drugs (called pharming). The first such pharming drug, approved in the United States for use in adults in 2012 and children in 2014, is an enzyme to treat Gaucher’s disease, a genetic disorder. This approach might also be used for the engineering of food crops containing high levels of all the amino acids essential to humans.